NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 165 filers reported holding NOVOCURE LTD in Q2 2018. The put-call ratio across all filers is 0.23 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,582 | -61.1% | 221,784 | 0.0% | 0.05% | -58.8% |
Q2 2023 | $9,204 | -31.0% | 221,784 | 0.0% | 0.12% | -35.0% |
Q1 2023 | $13,338 | -38.7% | 221,784 | -25.3% | 0.18% | -36.7% |
Q4 2022 | $21,769 | -99.9% | 296,784 | 0.0% | 0.29% | -7.1% |
Q3 2022 | $22,550,000 | +9.3% | 296,784 | 0.0% | 0.31% | +20.1% |
Q2 2022 | $20,626,000 | -16.1% | 296,784 | 0.0% | 0.26% | -3.4% |
Q1 2022 | $24,589,000 | +35.5% | 296,784 | +22.7% | 0.27% | +56.7% |
Q4 2021 | $18,153,000 | +39.8% | 241,784 | +116.3% | 0.17% | +28.6% |
Q3 2021 | $12,986,000 | -47.6% | 111,784 | 0.0% | 0.13% | -47.8% |
Q2 2021 | $24,796,000 | +48.0% | 111,784 | -11.8% | 0.26% | +55.5% |
Q1 2021 | $16,758,000 | -40.1% | 126,784 | -21.6% | 0.16% | -41.4% |
Q4 2020 | $27,995,000 | +4.0% | 161,784 | -33.1% | 0.28% | -7.6% |
Q3 2020 | $26,913,000 | +32.8% | 241,784 | -29.3% | 0.30% | +27.8% |
Q2 2020 | $20,268,000 | +80.5% | 341,784 | +104.9% | 0.24% | +51.0% |
Q1 2020 | $11,231,000 | -20.1% | 166,784 | 0.0% | 0.16% | -6.5% |
Q4 2019 | $14,055,000 | +12.7% | 166,784 | 0.0% | 0.17% | +6.3% |
Q3 2019 | $12,472,000 | -5.2% | 166,784 | -19.8% | 0.16% | -3.7% |
Q2 2019 | $13,156,000 | +152.8% | 208,059 | +92.5% | 0.16% | +148.5% |
Q1 2019 | $5,205,000 | +10.2% | 108,059 | -23.4% | 0.07% | -2.9% |
Q4 2018 | $4,724,000 | -45.3% | 141,094 | -14.5% | 0.07% | -38.7% |
Q3 2018 | $8,644,000 | +29.6% | 164,953 | -22.6% | 0.11% | +19.4% |
Q2 2018 | $6,672,000 | +81.8% | 213,153 | +26.6% | 0.09% | +66.1% |
Q1 2018 | $3,669,000 | -4.8% | 168,321 | -11.8% | 0.06% | 0.0% |
Q4 2017 | $3,854,000 | -15.8% | 190,800 | -17.2% | 0.06% | -13.8% |
Q3 2017 | $4,575,000 | -3.3% | 230,500 | -15.8% | 0.06% | -9.7% |
Q2 2017 | $4,733,000 | – | 273,600 | – | 0.07% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Nordwand Advisors, LLC | 1,515,000 | $111,125,249 | 13.86% |
Invus Financial Advisors, LLC | 350,884 | $25,737,341 | 13.70% |
HARTLINE INVESTMENT CORP/ | 304,482 | $22,333,755 | 5.08% |
GREAT POINT PARTNERS LLC | 241,000 | $17,677,350 | 3.46% |
Tri Locum Partners LP | 72,400 | $5,311,000 | 2.15% |
Taylor Frigon Capital Management LLC | 42,061 | $3,085,174 | 1.75% |
HighVista Strategies LLC | 28,007 | $2,054,313 | 1.22% |
HAP Trading, LLC | 124,500 | $10,294 | 1.05% |
Private Harbour Investment Management & Counsel, LLC | 12,285 | $901,105 | 0.99% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 32,000 | $2,344,000 | 0.72% |